It’s difficult to identify the pathogen that will cause the next pandemic. No-one predicted SARS-CoV-2, so it’s critical that we are prepared for threats both known and unknown.
A future is possible where therapeutics are rapidly available following the identification of a novel virus, reducing the overwhelming devastation of a potential pandemic. Yet, this is only possible through continued significant investment in ‘always on’ research and development.
We will focus on developing platform technologies that will apply to any future pandemic, no matter the pathogen. This ‘plug and play’ approach aims to make pandemic therapeutic treatments available in much shorter timeframes than currently possible.
Platform Technologies
- Antibodies and nanobodies
- Small molecules
- Host targets
- Nucleic acid targeting
- Fundamental virology, bacteriology and immunology
- Enabling capabilities